Lincoln National Corp lifted its position in shares of John Hancock Multifactor Mid Cap ETF (NYSEARCA:JHMM – Get Rating) by 27.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,690 shares of the company’s stock after acquiring an additional 4,451 shares during the period. Lincoln National Corp’s holdings in John Hancock Multifactor Mid Cap ETF were worth $881,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Steph & Co. acquired a new stake in shares of John Hancock Multifactor Mid Cap ETF during the 3rd quarter valued at approximately $30,000. FMR LLC raised its position in shares of John Hancock Multifactor Mid Cap ETF by 300.0% during the 2nd quarter. FMR LLC now owns 1,148 shares of the company’s stock valued at $51,000 after acquiring an additional 861 shares in the last quarter. National Bank of Canada FI increased its position in John Hancock Multifactor Mid Cap ETF by 65.6% in the second quarter. National Bank of Canada FI now owns 1,325 shares of the company’s stock worth $58,000 after buying an additional 525 shares during the period. JPMorgan Chase & Co. increased its position in John Hancock Multifactor Mid Cap ETF by 44.7% in the second quarter. JPMorgan Chase & Co. now owns 3,123 shares of the company’s stock worth $138,000 after buying an additional 965 shares during the period. Finally, Private Trust Co. NA acquired a new stake in John Hancock Multifactor Mid Cap ETF in the second quarter worth $181,000.
John Hancock Multifactor Mid Cap ETF Stock Down 0.4 %
Shares of NYSEARCA JHMM opened at $49.24 on Wednesday. John Hancock Multifactor Mid Cap ETF has a 1-year low of $41.96 and a 1-year high of $53.99. The business’s fifty day moving average price is $47.86 and its two-hundred day moving average price is $46.94.
Further Reading
- Get a free copy of the StockNews.com research report on John Hancock Multifactor Mid Cap ETF (JHMM)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Want to see what other hedge funds are holding JHMM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for John Hancock Multifactor Mid Cap ETF (NYSEARCA:JHMM – Get Rating).
Receive News & Ratings for John Hancock Multifactor Mid Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Hancock Multifactor Mid Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.